Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("ANTICOMPLEMENTARY ACTIVITY")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 147

  • Page / 6
Export

Selection :

  • and

THE INVOLVEMENT OF LYT-2 ANTIGENS IN THE LYSIS OF VIRUS-INFECTED TARGET CELLS BY ANTIGEN SPECIFIC ANTI-VESICULAR STOMATIS VIRUS CYTOTOXIC T-LYMPHOCYTESHALE AH.1981; IMMUNOL. LETT.; ISSN 0165-2478; NLD; DA. 1981; VOL. 3; NO 3; PP. 179-181; BIBL. 14 REF.Article

COMPLEMENT-FIXATION TEST FOR ROTAVIRUS DETECTION: COMPARISON AND ANALYSIS OF DIFFERENT METHODS TO REDUCE ANTI-COMPLEMENTARY ACTIVITY OF SOME SPECIMENSPAURI P; BAGNARELLI P; CLEMENTI M et al.1982; J. VIROL. METHODS; ISSN 0166-0934; NLD; DA. 1982; VOL. 3; NO 6; PP. 329-335; BIBL. 12 REF.Article

STUDIES ON THE NATURE OF HEAT-LABILE ANTI-COMPLEMENTARY ACTIVITY IN NORMAL HUMAN SERUMSOLTIS RD; HASZ D; MORRIS MJ et al.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 37; NO 2; PP. 310-322; BIBL. 30 REF.Article

PREPARATION OF HUMAN IMMUNOGLOBULIN FREE OF PLASMIN AND ANTICOMPLEMENT ACTIVITIES.HABEEB AFSA; FRANCIS RD.1977; VOX SANG.; SUISSE; DA. 1977; VOL. 32; NO 3; PP. 143-158; BIBL. 30 REF.Article

ANTICOMPLEMENTARY ACTIVITY IN MULTIPLE SCLEROSISRYBERG B.1983; JOURNAL OF THE NEUROLOGICAL SCIENCES; ISSN 0022-510X; NLD; DA. 1983; VOL. 59; NO 2; PP. 175-183; BIBL. 2 P.Article

ANTIBODY SPECTRUM AND ANTICOMPLEMENTARY ACTIVITY OF A PLASMIN-TREATED HUMAN IMMUNOGLOBULIN PREPARATIONMASUDA K; MAKULA MF; OKUYAMA K et al.1982; VOX SANG.; ISSN 0042-9007; CHE; DA. 1982; VOL. 42; NO 1; PP. 8-15; BIBL. 8 REF.Article

ISOLATION OF NON-ANTICOMPLEMENTARY HUMAN IMMUNOGLOBULIN BY COHN FRACTIONATION OF HEATED PLASMASTEPHAN W.1979; J. CLIN. CHEM. CLIN. BIOCHEM.; DEU; DA. 1979; VOL. 17; NO 12; PP. 799-801; ABS. GER; BIBL. 7 REF.Article

DETECTION OF CIRCULATING ANTICOMPLEMENTARY FACTORS IN CHRONIC LUNG DISEASES.HILTON A; MOORE M; HOWAT JMT et al.1978; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1978; VOL. 31; NO 2; PP. 237-243; BIBL. 16 REF.Article

THE ANTICOMPLEMENTARY ACTIVITY OF LIPOPOLYSACCHARIDE PREPARATIONS AND SONICATES FROM A STRAIN OF FUSOBACTERIUM NUCLEATUM.HAWLEY CE; FALKLER WA.1978; J. PERIODONT. RES.; DENM.; DA. 1978; VOL. 13; NO 1; PP. 24-36; BIBL. 1 P. 1/2Article

VENOM OF THE ANT PSEUDOMYRMEX SP.: FURTHER CHARACTERIZATION OF TWO FACTORS THAT AFFECT HUMAN COMPLEMENT PROTEINS.SCHULTZ DR; ARNOLD PI.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 5; PP. 1690-1699; BIBL. 37 REF.Article

HEMOLYTIC COMPLEMENT ACTIVITY IN NORMAL HUMAN DONOR CORNEASMONDINO BJ; HOFFMAN DB.1980; ARCH. OPHTHALMOL.; ISSN 0003-9950; USA; DA. 1980; VOL. 98; NO 11; PP. 2041-2044; BIBL. 9 REF.Article

CORRELATION ENTRE LE POUVOIR ANTICOMPLEMENTAIRE DES SERUMS HUMAINS ET LA PRESENCE DE COMPLEXES IMMUNS CIRCULANTSDEVILLE CHABROLLE A; PARIS HAMELIN A.1980; NOUV. PRESSE MED.; FRA; DA. 1980; VOL. 9; NO 31; PP. 2163; BIBL. 3 REF.Article

ACTIVATION OF MURINE COMPLEMENT BY COBRA VENOM FACTOR IN THE PRESENCE OF EDTAGOLDMAN JN; BANGALORE S; GOLDMAN MB et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 5; PP. 2421-2427; BIBL. 16 REF.Article

INTRAVENOESES HUMAN-IMMUNGLOBULIN DURCH CHEMISCHE MODIFIZIERUNG MIT BETA -PROPIOLACTON. RADIOCHEMISCHE UNTERSUCHUNGEN = UNE IMMUNOGLOBULINE HUMAINE INTRAVEINEUSE OBTENUE PAR MODIFICATION CHIMIQUE PAR LA BETA -PROPIOLACTONE. RECHERCHES RADIOCHIMIQUESSTEPHAN W; FASOLD H.1980; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1980; VOL. 30; NO 12; PP. 2090-2093; ABS. ENG; BIBL. 16 REF.Article

COMPLEMENT INHIBITION BY AMIDINES AND GUANIDINES - IN VIVO AND IN VITRO RESULTSOTTERNESS IG; TORCHIA AJ; DOSHAN HD et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 14; PP. 1873-1878; BIBL. 29 REF.Article

INHIBITION OF THE HAEMOLYTIC COMPLEMENT ACTIVITY BY DERIVATIVES OF BENZAMIDINE.HAUPTMANN J; MARKWARDT F.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 4; PP. 325-329; BIBL. 32 REF.Article

AN ANTICOMPLEMENTARY AGENT, K-76 MONOCARBOXYLIC ACID: ITS SITE AND MECHANISM OF INHIBITION OF THE COMPLEMENT ACTIVATION CASCADEHONG K; KINOSHITA T; MIYAZAKI W et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 6; PP. 2418-2423; BIBL. 19 REF.Article

ANTICOMPLEMENTARY ACTIVITY OF CORNEAL VITREOUS AND CHORIORETINA IN RABBITSLIAO HR; MINTA JO; BASU PK et al.1979; CANAD. J. OPHTHALMOL.; CAN; DA. 1979; VOL. 14; NO 4; PP. 270-273; ABS. FRE; BIBL. 12 REF.Article

THE EFFECTS OF HUMAN SALIVA ON THE HEMOLYTIC ACTIVITY OF COMPLEMENTBOACKLE RJ; PRUITT KM; SILVERMAN MS et al.1978; J. DENT. RES.; USA; DA. 1978; VOL. 57; NO 1; PP. 103-110; BIBL. 22 REF.Article

ACTIVITES ANTICOMPLEMENTAIRES DE SUBSTANCES HEPARINIQUES ET PROTANINIQUES.TIMSIT J; GIROUD JP.1976; C.R. SOC. BIOL.; FR.; DA. 1976; VOL. 170; NO 3; PP. 567-574; ABS. ANGL.; BIBL. 6 REF.Article

ISOLATION AND PARTIAL CHARACTERIZATION OF A POLYSACCHARIDE IN ANT VENOM (PSEUDOMYRMEX SP.) THAT ACTIVATES THE CLASSICAL COMPLEMENT PATHWAYSCHULTZ DR; ARNOLD PI; WU MC et al.1973; MOL. IMMUNOL.; GBR; DA. 1973; VOL. 16; NO 4; PP. 253-264; BIBL. 44 REF.Article

STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE FORMATION OF THE HUMAN AMPLIFICATION C3 CONVERTASEKAZATCHKINE MD; FEARON DT; METCALFE DD et al.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 67; NO 1; PP. 223-228; BIBL. 35 REF.Article

AN IMPROVED METHOD FOR THE ISOLATION FROM NAJA NAJA VENOM OF COBRA FACTOR (COF) FREE OF PHOSPHOLIPASE APEPYS MB; TOMPKINS C; SMITH AD et al.1979; J. IMMUNOL. METHODS; NLD; DA. 1979; VOL. 30; NO 2; PP. 105-117; BIBL. 24 REF.Article

STUDIES ON SOME BIOLOGICALLY ACTIVE DEXTRANSPREOBRAZHENSKAYA ME; ROSENFELD EL; KANDRA L et al.1978; CARBOHYD. RES.; NLD; DA. 1978; VOL. 66; PP. 213-223; BIBL. 38 REF.Article

SERUM REACTIONS. AN ANALYSIS OF COMMERCIAL ANTIVENOMS AND THE POSSIBLE ROLE OF ANTICOMPLEMENTARY ACTIVITY IN DE-NOVO REACTIONS TO ANTIVENOMS AND ANTITOXINS.SUTHERLAND SK.1977; MED. J. AUSTRAL.; AUSTRAL.; DA. 1977; VOL. 1; NO 17; PP. 613-615; BIBL. 16 REF.Article

  • Page / 6